LB2101
/ Legend Biotech
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
June 14, 2022
GPC3-targeting LCAR-H93T Cell in Treatment of Advanced Hepatocellular Carcinoma
(clinicaltrials.gov)
- P1 | N=34 | Recruiting | Sponsor: jianming xu | Not yet recruiting ➔ Recruiting
Enrollment open • Gastrointestinal Cancer • Hepatocellular Cancer • Oncology • Solid Tumor • GPC3
April 29, 2022
GPC3-targeting LCAR-H93T Cell in Treatment of Advanced Hepatocellular Carcinoma
(clinicaltrials.gov)
- P1 | N=34 | Not yet recruiting | Sponsor: jianming xu
New P1 trial • Gastrointestinal Cancer • Hepatocellular Cancer • Oncology • Solid Tumor • GPC3
1 to 2
Of
2
Go to page
1